GMO TECH, Inc.

As of June 30, 2024, GMO TECH, Inc. has 1.07M shares outstanding.

As of June 30, 2024, GMO TECH, Inc. trades at a trailing price-to-earnings ratio of 24.14. The price-to-sales ratio is 1.81, and the price-to-book ratio stands at 19.43.

As of June 30, 2024, GMO TECH, Inc. trades at an EV/EBITDA multiple of 15.36 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.68 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 15.36 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. GMO TECH, Inc. trades at an EV/FCF ratio of 9,044.21, comparing the total takeover cost of the business to the cash it actually generates for all capital providers.

As of June 30, 2024, GMO TECH, Inc. maintains a current ratio of 1.63, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 25.26, indicating elevated leverage, while an interest coverage ratio of 389.50 demonstrates strong ability to service its debt obligations.

These figures cover the twelve months ended June 30, 2024. Return on invested capital (ROIC) comes in at 43.55 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 21.70, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 111.78, useful for judging operating efficiency across full business cycles.

These figures cover the twelve months ended June 30, 2024. That works out to an effective tax rate of 33.87, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items.

As of the close on October 23, 2025, GMO TECH, Inc.'s stock has declined approximately 30.25% over the past 52 weeks. The 50-day moving average sits at 6,237.30, while the 200-day moving average is 7,534.98.

Over the twelve months ended June 30, 2024, GMO TECH, Inc. posted a gross margin of 39.73, reflecting its pricing power and cost economics. The operating margin of 10.97 and net profit margin of 7.51 provide insight into operational efficiency.

As of June 30, 2024, GMO TECH, Inc. has an Altman Z-Score of 9.78, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.